Earnings Analysis to Watch: Weed Inc (BUDZ), Earth Science Tech Inc (ETST),Cannlabs Inc (CANL)

Earnings Analysis to Watch: Weed Inc (BUDZ), Earth Science Tech Inc (ETST),Cannlabs Inc (CANL)

Earnings Analysis to Watch: Weed Inc (BUDZ), Earth Science Tech Inc (ETST),Cannlabs Inc (CANL)

Weed Inc (OTCMKTS:BUDZ) showing dropped of -4.55% and closed at $2.10, after gaining total volume of 47,647.00 shares. Its earnings per share (EPS) is -$0.16 and its beta value stands at -3.30 points and has total market capitalization of $ 232.01M and a total of 64.80 million outstanding shares.

WEED, Inc. focuses on purchasing land and building commercial grade cultivation centers for the legal and medical marijuana sector in the United States. The company intends to consult, assist, manage, and lease its cultivation centers to licensed dispensary owners and organic grow operators. The company was formerly known as United Mines, Inc. and changed its name to WEED, Inc. in February 2015. WEED, Inc. was founded in 1999 and is based in Tucson, Arizona.

Earth Science Tech Inc (OTCMKTS:ETST) reported the plunge of -3.85% and closed at $1.25, with the total traded volume of 39,714.00 shares. During last trade its minimum price was $1.14 and it gained its highest price of $1.31 and has a total of 40.91 million outstanding shares.

On March 9, 2017 Earth Science Tech, Inc. (ETST), an innovative biotech company focused on cannabis (industrial hemp) and cannabinoid research and development, nutraceuticals, pharmaceuticals, and medical devices, is pleased to announce it has formulated a new Cannabis CBD-based pre-workout sports supplement with Forzagen. Additionally, the company’s joint venture with Karmavore Superfoods is off to a good start, and their chocolates (infused with ETST CBD) are selling well.

The company recently announced a joint venture with Nutrition Specialties and Forzagen, (Earth Science Tech, Enters Multi-Billion Dollar Sports Supplement Industry via Joint Venture with Nutrition Specialties and Forzagen) where Earth Science Tech and Forzagen will formulate new CBD-based sports products. Earth Science Tech will help develop the market in the United States while Forzagen will develop the market in Mexico and other international accounts. Earth Science Tech, together with Forzagen, have formulated a full-spectrum CBD-based pre-workout supplement called Black Demon 2.0. The supplement was formulated for serious athletes, and is incredibly potent. Forzagen and Earth Science Tech will be splitting both the costs and revenues of Black Demon 2.0, and it is currently in the label design phase. It is expected to be bottled and start selling within Q2 or Q3 of 2017.

“We have seen great success with our non-CBD products in the past, but we are expecting even greater success with Black Demon 2.0,” said Forzagen owner, Jose Bucay, “We’ve already have competitive athletes testing the supplement, and have nothing but positive feedback in regards to Black Demon 2.0. We think we’ve got a true hit in the making.”

Cannlabs Inc (OTCMKTS:CANL) decreased -1.66% closed at $0.290 and traded with total volume of 11,000.00 shares, while the average trading remained 24,365.00 shares. During last trade its minimum price was $0.29 and it gained the highest price of $0.33. Its market capitalization was $17.63 million.

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.

 

Leave a reply

0 Comments

There are no comments on this post.

Risk Warning: Investing in digital currencies, stocks, shares and other securities, commodities, currencies and other derivative investment products (e.g. contracts for difference (“CFDs”) is speculative and carries a high level of risk. Each investment is unique and involves unique risks.

CFDs and other derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how an investment works and whether you can afford to take the high risk of losing your money.

Cryptocurrencies can fluctuate widely in prices and are, therefore, not appropriate for all investors. Trading cryptocurrencies is not supervised by any EU regulatory framework. Past performance does not guarantee future results. Any trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Your capital is at risk.

When trading in stocks your capital is at risk.

Past performance is not an indication of future results. Trading history presented is less than 5 years old unless otherwise stated and may not suffice as a basis for investment decisions. Prices may go down as well as up, prices can fluctuate widely, you may be exposed to currency exchange rate fluctuations and you may lose all of or more than the amount you invest. Investing is not suitable for everyone; ensure that you have fully understood the risks and legalities involved. If you are unsure, seek independent financial, legal, tax and/or accounting advice. This website does not provide investment, financial, legal, tax or accounting advice. Some links are affiliate links. For more information please read our full risk warning and disclaimer.